Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study (Q34495483)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Yokukansan (TJ-54) for treatment of pervasive developmental disorder not otherwise specified and Asperger's disorder: a 12-week prospective, open-label study (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Asperger syndrome

0 references

pervasive developmental disorder not otherwise specified

0 references

author name string

Tsuyoshi Miyaoka

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rei Wake

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Motohide Furuya

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kristian Liaury

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Masa Ieda

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Kazunori Kawakami

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Keiko Tsuchie

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Takuji Inagaki

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jun Horiguchi

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

29 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

215

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Recent advances in the pharmacotherapy of autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Epidemiology of Pervasive Developmental Disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Neurochemistry in the pathophysiology of autism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Epidemiology of autistic disorder and other pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Acute and long-term safety and tolerability of risperidone in children with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

The effectiveness and tolerability of aripiprazole for pediatric bipolar disorders: a retrospective chart review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Aripiprazole for maladaptive behavior in pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Regression to the mean: what it is and how to deal with it.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Quetiapine in nine youths with autistic disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Defining the broader phenotype of autism: genetic, brain, and behavioral perspectives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Risperidone in children with autism and serious behavioral problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Evaluation of the protective effects of alkaloids isolated from the hooks and stems of Uncaria sinensis on glutamate-induced neuronal death in cultured cerebellar granule cells from rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

On the methods and theory of reliability.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

6 July 2018

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Pharmacologic Treatment of Behavioral Symptoms Associated With Autism and Other Pervasive Developmental Disorders

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Effects of Yoku-kan-san-ka-chimpi-hange on the sleep of normal healthy adult subjects

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Yi-gan san for the treatment of borderline personality disorder: an open-label study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Charles Bonnet syndrome: successful treatment of visual hallucinations due to vision loss with Yi-gan san.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education.

1 reference

https://api.crossref.org/works/10.1186%2F1471-244X-12-215

21 January 2018

Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

27 October 2018

Effects of the traditional Chinese herbal medicine Yi-Gan San for cholinesterase inhibitor-resistant visual hallucinations and neuropsychiatric symptoms in patients with dementia with Lewy bodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3533891

27 October 2018

Evaluation with receptor binding assay on the water extracts of ten CNS-active Chinese herbal drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/23194148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yi-gan san for treatment of charles bonnet syndrome (visual hallucination due to vision loss): an open-label study

1 reference

https://pubmed.ncbi.nlm.nih.gov/23194148

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-244X-12-215

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34495483&oldid=2196709988"